arrow
F

Fareed Khawaja

university of texas system
H指数:17
被引数:941

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Respiratory Syncytial Virus Exceeded SARS-CoV-2 and Influenza in Lower Respiratory Infection and Mortality Rates Among Patients With Hematologic Malignancies During the 2023–2024 Respiratory Virus Season

呼吸道合胞病毒在2023–2024年呼吸道病毒季节中,在血液恶性肿瘤患者的下呼吸道感染率和死亡率方面超过了SARS-CoV-2和流感。

2025-10-080
OAAI
Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th European Conference on Infections in Leukaemia

血液系统恶性肿瘤患者或造血细胞移植受者中的社区获得性呼吸道病毒感染:第10届欧洲白血病感染会议更新建议

2025-08-270
OAAI
The interplay between Epstein-Barr Virus and Cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation in the era of primary CMV prophylaxis

同种异基因造血细胞移植后,在主要巨细胞病毒(CMV)预防时代,爱泼斯坦-巴尔病毒(Epstein-Barr Virus)与巨细胞病毒(Cytomegalovirus)再激活的相互作用

2025-08-250
PRE
American Society for Transplantation and Cellular Therapy Series #11: Updated Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and Cellular Therapy Recipients

美国移植与细胞治疗学会系列 #11:造血细胞移植和细胞治疗受者巨细胞病毒指南更新

2025-06-010
OAAI
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Trials

免疫功能低下患者难治性和耐药性单纯疱疹病毒黏膜皮肤感染:文献综述及临床试验中拟用定义

2025-01-291
OA
Prevention and Treatment of Cancer-Related Infections, Version 3.2024

癌症相关感染的预防和治疗,3.2024版

2024-11-010
PRE
Humoral Immunity and Antibody Responses against Diphtheria, Tetanus, and Pneumococcus after Immune Effector Cell Therapies: A Prospective Study

免疫效应细胞治疗后针对白喉、破伤风和肺炎球菌的体液免疫和抗体反应: 一项前瞻性研究

2024-09-190
OAAI
Clinical Utility of Plasma Microbial Cell-Free DNA Sequencing Among Immunocompromised Patients With Pneumonia
2024-07-222
OAAI
Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes
2024-07-183
OAAI
Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis: a single-centre retrospective experience
2024-06-011
PRE